Price $2.73 |
Market Cap
183.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.42
|
P/S
1.6
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
24.9
|
Op. Cash Flow
8.7K
|
FCF
0.1
|
|
Op. Margin
-1.50%
|
Net Margin
-4.80%
|
ROE
-7.40%
|
ROI
-6.10%
|
|
ROA
-3.70%
|
EPS Growth
-47.00%
|
Current Ratio
2.2
|
Debt/Equity
59.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
